E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/12/2014 in the Prospect News Structured Products Daily.

New Issue: UBS prices $232,000 airbag phoenix autocallables linked to Regeneron Pharmaceuticals

By Toni Weeks

San Luis Obispo, Calif., Nov. 12 – UBS AG, London Branch priced $232,000 of airbag phoenix autocallable optimization securities due May 13, 2016 linked to the common stock of Regeneron Pharmaceuticals, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

Each month, the notes will pay a contingent coupon at the rate of 9.7% per year if Regeneron shares close at or above the coupon barrier, 70% of the initial share price, on the observation date for that month.

The notes will be automatically called at par if Regeneron shares close at or above the initial share price on any autocall observation date, which occur quarterly.

If the notes are not called and the final price of Regeneron shares is greater than or equal to the conversion price, 85% of the initial share price, the payout at maturity will be par. Otherwise, investors will receive a number of Regeneron shares equal to $1,000 divided by the conversion price.

UBS Financial Services Inc. and UBS Investment Bank are the agents.

Issuer:UBS AG, London Branch
Issue:Airbag phoenix autocallable optimization securities
Underlying stock:Regeneron Pharmaceuticals, Inc. (Symbol: REGN)
Amount:$232,000
Maturity:May 13, 2016
Coupon:9.7% annualized for each month Regeneron shares close at or above coupon barrier on observation date for that month
Price:Par
Payout at maturity:If final share price is greater than or equal to conversion price, par; otherwise, 3.1137 Regeneron shares
Call:At par if Regeneron shares close at or above initial share price on any quarterly autocall observation date
Initial share price:$377.84
Coupon barrier:$264.49, 70% of initial share price
Conversion price:$321.16, 85% of initial share price
Pricing date:Nov. 7
Settlement date:Nov. 13
Agents:UBS Financial Services Inc. and UBS Investment Bank
Fees:1.5%
Cusip:90274B873

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.